ICU Medical, Inc. engages in the development, manufacture, and sale of medical technologies used in vascular therapy, oncology, and critical care applications. The company?s product line includes custom intravenous (I.V.) systems, closed delivery systems for hazardous drugs, needleless I.V. connectors, catheters, and cardiac monitoring systems. Its products enhance patient outcomes by preventing bloodstream infections, protecting healthcare workers and patients from exposure to infectious diseases or hazardous drugs, and monitoring the hemodynamic status of critical care patients. The company offers I.V. therapy lines consisting of a tube running from a bottle or plastic bag containing an I.V. solution to a catheter inserted in a patient?s vein for use in hospitals and ambulatory clinics; CLAVE product, a needleless I.V. connection device, which would be used with conventional peripheral or central vascular access systems for venous and arterial applications; custom infusion sets, custom oncology sets, and custom critical care sets; and CLC2000, which is used to connect I.V. lines to catheters to prevent the back-flow of blood into the catheter. It also provides critical care products that monitor vital signs and specific physiological functions of key organ systems, including pressure monitoring devices, blood sampling systems, angiography kits, sensory catheters, pulmonary artery thermodilution catheters, and multi-lumen central venous catheters. In addition, the company provides TEGO for use in dialysis; the Orbit 90 diabetes sets; a line of oncology products, including Spiros male luer connector device; the Genie vial access device; and custom I.V. sets and ancillary products for chemotherapy. ICU Medical, Inc. sells its products through I.V. product manufacturers and independent distributors, as well as directly to the end users in the United States and internationally
